EverSource Wealth Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
EverSource Wealth Advisors's KPTI Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 15 shares worth $18. The stake represents ﹤0.01% of the portfolio and ranks #4503 among its holdings.
59 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- EverSource Wealth Advisors held 15 shares of Karyopharm Therapeutics worth $18 as of Q3 2026.
- Karyopharm Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4503 holding.
- 59 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.